Quantification of PI3K/AKT/mTOR pathway inhibition is predictive of biological response

被引:0
|
作者
Van Brussel, A. [1 ]
Wesseling-Rozendaal, Y. [1 ]
Den Biezen, E. [1 ]
Neerken, S. [1 ]
van de Wiel, P. [1 ]
机构
[1] InnoSIGN, Res & Dev, Eindhoven, Netherlands
关键词
D O I
10.1016/j.ejca.2024.114726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PB196
引用
收藏
页码:S81 / S81
页数:1
相关论文
共 50 条
  • [1] Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis
    Barra, Fabio
    Desideri, Lorenzo Ferro
    Ferrero, Simone
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (17) : 3626 - 3627
  • [2] Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
    LoRusso, Patricia Mucci
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3803 - +
  • [3] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [4] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [5] Vertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis
    Chen, Jiezhong
    Crawford, Ross
    Xiao, Yin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (02) : 245 - 249
  • [6] Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis Reply
    Matsuzaki, Sachiko
    Pouly, Jean-Luc
    Canis, Michel
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (17) : 3628 - 3629
  • [7] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21
  • [8] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [9] Predictive and pharmacodynamic (PD) markers of PI3K pathway inhibitors: focus on PI3K, AKT and mTOR inhibitors
    Tabernero, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S6 - S6
  • [10] Prognostic and predictive role of the PI3K–AKT–mTOR pathway in neuroendocrine neoplasms
    P. Gajate
    T. Alonso-Gordoa
    O. Martínez-Sáez
    J. Molina-Cerrillo
    E. Grande
    Clinical and Translational Oncology, 2018, 20 : 561 - 569